Elusys Therapeutics Finalizes HHS Contract to Deliver Inhalation Anthrax Treatment
Elusys Therapeutics, which is being acquired by Heat Biologics, has finalized a contract with the U.S. Department of Health and Human Services ...
Elusys Therapeutics, which is being acquired by Heat Biologics, has finalized a contract with the U.S. Department of Health and Human Services ...
While the world is still reeling from the COVID-19 pandemic, public health and emergency management experts are already preparing for ...
A Labor government would set up an Australian Centre for Disease Control to strengthen the country’s preparedness for future pandemics ...
Amid unpredictable outbreaks, and fears of a second wave, the hunt is on for a vaccine against COVID-19. The reason ...
COVID-19 is being referred to as a “once in a century event” – but the next pandemic is likely to ...
Today Congresswomen Susan W. Brooks (R-IN05) and Kim Schrier, M.D. (D-WA08) introduced H.R. 6517, the Stockpiling for America’s Future Endeavors ...
“It should not take public pleas from governors or letters from congressional delegations for states to obtain the supplies they ...
Approximately 500,000 testing swabs and supplies were flown by Air Mobility Command on March 19-20 from Aviano Air Base, Italy, ...
The Johns Hopkins Center for Health Security, World Economic Forum and Bill & Melinda Gates Foundation have issued 7 recommendations ...
Many health security threats involve bacteria or chemicals for which clinical trials cannot be performed in humans. To overcome this ...
A new vaccine approved in the U.S. on Sept. 24 prevents both smallpox and the related disease monkeypox in adults. ...
The FDA approved the Jynneos Smallpox and Monkeypox Vaccine last week. The live, non-replicating vaccine is made from a vaccinia ...
The U.S. Food and Drug Administration announced today the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the ...
The the nation’s largest reserve of medicines and supplies for use in a public health emergency – the Strategic National ...
The U.S. Food and Drug Administration (FDA) clearance Silverlon, a product to manage certain blister injuries caused by sulfur mustard, ...
The Biomedical Advanced Research and Development Authority (BARDA) annual Industry Day 2019 conference on U.S. government medical countermeasures is planned ...
A crisis has arisen from the simultaneous decrease in the number of pharmaceutical companies developing antibiotics and the dramatic increase ...
Bavarian Nordic A/S announced on Jan. 18 that the U.S. Biomedical Advanced Research and Development Authority (BARDA) has exercised another ...
SIGA Technologies, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United ...
The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price contract to Emergent ...